Long-lived antibodies increase the effectiveness of anti-cancer drugs
A change in the structure of the stable site of antitumor monoclonal antibodies led to an increase in the duration of their "life" in the body and, accordingly, to an increase in the effectiveness of treatment.
11.02.2010